IL1B and melanoma: Moreover, the progression of melanoma was found to be associated with elevated concentrations of IL-1β as compared to patients with stable disease, and enrichment of circulating monocytic MDSCs significantly correlated with a decreased progression free survival of melanoma patients (60).